JPS6045190B2 - Piprazine derivative - Google Patents
Piprazine derivativeInfo
- Publication number
- JPS6045190B2 JPS6045190B2 JP51074057A JP7405776A JPS6045190B2 JP S6045190 B2 JPS6045190 B2 JP S6045190B2 JP 51074057 A JP51074057 A JP 51074057A JP 7405776 A JP7405776 A JP 7405776A JP S6045190 B2 JPS6045190 B2 JP S6045190B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- lower alkyl
- pyridyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は、一般式
′−ヘ
Y− B−″N■R1
〔I〕
式中、
A及びB■低級アルキレン基:
R1■低級アルキル基、ヒドロキシ低級アルキル基、ア
リール基、ピリジル基、アルアルキル基、アニル基また
はピリジル低級アルキル基;
R2■水素原子、ハロゲン原子、アミノ基、ニトロ基ま
たは水酸基;及びY=アミノ基、低級アルキルアミノ基
、アルアルキルアミノ基、水酸基、一般式R3CONH
−(式中、R゜は水素原子、低級アルキル基、アリール
基またはピリジル基)で示される基または一般式ア℃0
0−(R゜は前記と同義)で示される基Jで示される新
規なピペラジン誘導体及びその塩に関する。Detailed Description of the Invention The present invention is based on the general formula '-HeY-B-''N■R1 [I] In the formula, A and B■Lower alkylene group: R1■Lower alkyl group, hydroxy lower alkyl group, aryl group, pyridyl group, aralkyl group, anyl group or pyridyl lower alkyl group; R2 ■ hydrogen atom, halogen atom, amino group, nitro group or hydroxyl group; and Y = amino group, lower alkylamino group, aralkylamino group, hydroxyl group , general formula R3CONH
- (wherein R° is a hydrogen atom, a lower alkyl group, an aryl group, or a pyridyl group) or a group represented by the general formula A℃0
The present invention relates to a novel piperazine derivative represented by the group J represented by 0- (R° is the same as defined above) and a salt thereof.
上記の各信号の定義をより具体的に説明すると、低級ア
ルキレン基とはメチレン、エチレン、プロピレン、トリ
メチレン、エチリデンなどを、低級アルキルとはメチル
、エチル、プロピル、イソプロピル、ブチルなどを、ヒ
ドロキシ低級アルキル基とはヒドロキシメチル、ヒドロ
キシエチル、ヒドロキシプロピルなどを、ハロゲン原子
とは塩素、臭素、フッ素などを、アリール基とはハロゲ
ン原子(前記と同義)、低級アルキル基(前記と同義)
、低級アルコキシ基(メトキシ、エトキシ、プロポキシ
、ブトキシなど)、トリフルオロメチル基などを置換基
として、任意の組合せで1個ないし複数個有しまたは有
さないフェニル基を、ピリジル基とは2−、3−または
4−ピリジル基を、アルアルキル基とはベンジル、フェ
ネチルなどを、ピリジル低級アルキルとは2−、3一ま
たは4−ピリジルメチル、2−、3−または4−ピリジ
ルエチルなどを、低級アルキルアミノとは、メチルアミ
ノ、エチルアミノ、プロピルアミとはベンゼン環にハロ
ゲン原子(前記と同義)を有しまたは有しないベンジル
アミアミノなどを、それぞれ示す。To explain the definition of each signal above more specifically, lower alkylene groups include methylene, ethylene, propylene, trimethylene, ethylidene, etc., lower alkyl refers to methyl, ethyl, propyl, isopropyl, butyl, etc., and hydroxy lower alkyl Groups include hydroxymethyl, hydroxyethyl, hydroxypropyl, etc. Halogen atoms include chlorine, bromine, fluorine, etc. Aryl groups include halogen atoms (same as above) and lower alkyl groups (same as above)
, a lower alkoxy group (methoxy, ethoxy, propoxy, butoxy, etc.), a trifluoromethyl group, etc. as a substituent, and a phenyl group with or without one or more in any combination; a pyridyl group is a 2- , 3- or 4-pyridyl group, aralkyl group includes benzyl, phenethyl, etc., pyridyl lower alkyl includes 2-, 3- or 4-pyridylmethyl, 2-, 3- or 4-pyridylethyl, etc. Lower alkylamino means methylamino, ethylamino, and propylamino means benzylamino with or without a halogen atom (as defined above) in the benzene ring, respectively.
本発明によれば一般式〔1〕のピペラジン誘導体は次の
方法によつて製造される。According to the present invention, the piperazine derivative of general formula [1] is produced by the following method.
(a) 一般式
〔式中Zは低級アルキレン基(前記と同義)、他の記号
は前記と同義〕で表わされる化合物を還元反応に付すこ
とにより得られる。(a) It can be obtained by subjecting a compound represented by the general formula [wherein Z is a lower alkylene group (same meaning as above) and other symbols have the same meanings as above] to a reduction reaction.
上記化合物〔■〕のカルボニル基をメチレン基まで還元
する方法には、(1)亜鉛アマルガムと5塩酸による還
元、(Ii)ジチオアセタールとなし、ニッケルで脱硫
的に還元、(Iii)ヒドラゾンとなし、塩基の存在下
に還元する方法などが一般的に知られているが、反応処
理上取扱が容易であるヒドラゾンとなし、塩基の存在下
に還元する・方法が好適である。The method for reducing the carbonyl group of the above compound [■] to a methylene group includes (1) reduction with zinc amalgam and pentahydrochloric acid, (Ii) reduction with dithioacetal and desulfurization with nickel, and (iii) reduction with hydrazone. Although methods such as reduction in the presence of a base are generally known, a method of reduction in the presence of a base using hydrazone, which is easy to handle in terms of reaction processing, is preferred.
即ち、一般式〔■〕の化合物とヒドラジン水和物を例え
ば第一級ブタノール中で加熱還流下に反応させると、一
般式〔式中、各記号は前記と同義〕で示されるヒドラゾ
ン誘導体が得られる。That is, when the compound of the general formula [■] and hydrazine hydrate are reacted in primary butanol under heating under reflux, a hydrazone derivative represented by the general formula [wherein each symbol has the same meaning as above] is obtained. It will be done.
この一般式〔■〕の化合物を例えばトルエン溶媒中、カ
リウム第三級ブチレートの存在下10〜2叫間加熱還流
することにより、あるいはジエチレングリコール、トリ
エチレングリコールなどの溶媒中、苛性カリの存在下1
50〜200℃に保つことによソー般式〔1〕の化合物
が得られる。更には、一般式〔■〕の化合物とヒドラジ
ン水和物と苛性カリとをジエチレングリコール(または
トリエチレングリコール)溶媒中同時に加え反応させる
ことによつても得られる。グリコール中苛性カリを用い
る反応の場合、一般式〔■〕において、Yがアシル誘導
体〔R3CONH−、R3COO一(R3は前記と同義
)〕の基を有する化合物〔■〕からは一般式〔式中、X
はアミノ基または水酸基を、他の各記号は前記と同義〕
で示される脱アシル化合物が得られることが多い。The compound of the general formula [■] is heated under reflux for 10 to 2 hours in a toluene solvent in the presence of potassium tertiary butyrate, or for 10 to 2 hours in the presence of caustic potassium in a solvent such as diethylene glycol or triethylene glycol.
By maintaining the temperature at 50 to 200°C, a compound of general formula [1] can be obtained. Furthermore, it can also be obtained by simultaneously adding and reacting the compound of the general formula [■], hydrazine hydrate, and caustic potassium in a diethylene glycol (or triethylene glycol) solvent. In the case of a reaction using caustic potassium in glycol, in the general formula [■], Y has a group of an acyl derivative [R3CONH-, R3COO- (R3 has the same meaning as above)]. X
represents an amino group or a hydroxyl group, and all other symbols have the same meanings as above]
The deacylated compound shown is often obtained.
J) 一般式〔1〕において、Yがアシル誘導体で示さ
れる化合物を製造するために、一般式〔■〕で示される
化合物を適当な脱酸剤、例えばトリエチルアミン、ピリ
ジンなど、あるいは炭酸ナトリウム、炭酸カリウムなど
の存在下、反応を阻害しない溶媒、例えばベンゼン、ト
ルエン、クロロホルム、テトラハイドロフランなどの溶
媒中で、アシル化剤、例えば無水酢酸、アセチルクロラ
イド、ベンゾイルクロライド、ニコチン酸クロライドを
作用させることにより得られる。J) In order to produce a compound in which Y is an acyl derivative in the general formula [1], the compound represented by the general formula [■] is treated with a suitable deoxidizing agent such as triethylamine, pyridine, etc., or sodium carbonate, carbonate, etc. By reacting an acylating agent such as acetic anhydride, acetyl chloride, benzoyl chloride, or nicotinic acid chloride in a solvent that does not inhibit the reaction, such as benzene, toluene, chloroform, or tetrahydrofuran in the presence of potassium or the like. can get.
−) 一般式〔1〕において、Yが低級アルキルアミノ
基またはアルアルキルアミノ基で示される化合物を製造
するために、一般式〔■〕において、xがアミノ基であ
る化合物と一般式〔式中、R4およびR5は同一または
異つて低級アルキル基(前記と同義)、アルアルキル基
(前記と同義)またはアリール基(前記と同義)を示し
、R4、R5の一方が水素原子でもよい〕で示される化
合物とを反応させて得られるイミノ化合物を還元するこ
とにより(この還元反応は、例えば水素化ホウ素ナトリ
ウムなど水素化金属錯化合物で処理することにより行な
われる)、または一般式〔1〕において、Yがアシル誘
導体である化合物を、例えばリチウムアルミニウムハイ
ドライドで還元することにより得られる。-) In order to produce a compound in which Y is a lower alkylamino group or an aralkylamino group in the general formula [1], a compound in which x is an amino group in the general formula [■] and a compound in the general formula [in the formula , R4 and R5 are the same or different and represent a lower alkyl group (same as above), an aralkyl group (same as above), or an aryl group (same as above), and one of R4 and R5 may be a hydrogen atom. (This reduction reaction is carried out, for example, by treatment with a metal hydride complex compound such as sodium borohydride), or in the general formula [1], It can be obtained by reducing a compound in which Y is an acyl derivative with, for example, lithium aluminum hydride.
上記方法で得られた一般式〔1〕の化合物は常法により
酸付加塩にすることが出来る。The compound of general formula [1] obtained by the above method can be converted into an acid addition salt by a conventional method.
酸付加塩を形成するための塩としては、例えば塩酸、硫
酸、臭化水素域、あるいはフマール酸、マレイン酸、ク
エン酸などから適宜選択することが出来る。一般式〔1
〕の化合物及びその酸付加塩は鎮痛作用、消炎作用、斗
争抑制作用、抗アボモルヒネ作用、降圧作用、末梢血管
拡張作用などの薬理作用を有し、消炎・鎮痛剤、抗精神
剤、抗不安剤、血圧降下剤などの医薬として、およびそ
れらの合成中間体として有用である。The salt for forming the acid addition salt can be appropriately selected from, for example, hydrochloric acid, sulfuric acid, hydrogen bromide, fumaric acid, maleic acid, citric acid, and the like. General formula [1
] and its acid addition salts have pharmacological effects such as analgesic, anti-inflammatory, anti-competition, anti-avomorphine, antihypertensive, and peripheral vasodilatory effects, and are used as anti-inflammatory/analgesic agents, antipsychotics, and anxiolytics. It is useful as a medicine, such as a hypotensive agent, and as a synthetic intermediate thereof.
次に本発明を実施例を挙げて具体的に説明する。Next, the present invention will be specifically described with reference to Examples.
実施例1
4−(4−アセチルアミノメチルフエナシルー1−(2
−メトキシフェニル)ピペラジン31.5y1ヒドラジ
ンヒドラート10mLをn−ブタノール200e中に加
え、6時間加熱還流する。Example 1 4-(4-acetylaminomethylphenacyl-1-(2
-Methoxyphenyl)piperazine 31.5y1 10 mL of hydrazine hydrate is added to n-butanol 200e and heated under reflux for 6 hours.
放冷後、氷水中に注ぎ込み、析出する結晶を?取、水洗
後乾燥すると、粗製のヒドラゾン33.7yが得られる
。このヒドラゾン33.7Vと苛性力1月0yをジエチ
レングリコール100m1中に加え、180〜200℃
に2時間加熱する。冷後、反応液に水を加えて生ずる油
状物をクロロホルム200m1で抽出、水洗し、無水炭
酸カリウムで脱水乾燥し、減圧下に濃縮して油状物を冷
却すると晶化する。これをイソプロピルエーテルから再
結晶すると無色鱗片状晶である融点87〜89℃の4−
〔2−(4−アミノメチルフェニル)エチル〕−1−(
2−メトキシフェニル)ピペラジン19.0yが得られ
る。実施例2
4−〔2−(4−アミノメチルフェニル)エチル〕−1
−(2−メトキシフェニル)ピペラジン6.6V1ニコ
チン酸クロライド・塩酸塩4.0y1トリエチルアミン
8m1をクロロホルム100m1中に加え、2時間加熱
還流する。After cooling, pour it into ice water to remove the crystals that precipitate. By taking, washing with water and drying, crude hydrazone 33.7y is obtained. Add this hydrazone 33.7 V and caustic strength 1 month 0 y to 100 ml of diethylene glycol, and heat at 180 to 200°C.
Heat for 2 hours. After cooling, water is added to the reaction solution, and the resulting oil is extracted with 200 ml of chloroform, washed with water, dehydrated and dried over anhydrous potassium carbonate, concentrated under reduced pressure, and crystallized when the oil is cooled. When this is recrystallized from isopropyl ether, 4-
[2-(4-aminomethylphenyl)ethyl]-1-(
19.0y of 2-methoxyphenyl)piperazine are obtained. Example 2 4-[2-(4-aminomethylphenyl)ethyl]-1
-(2-methoxyphenyl)piperazine 6.6V1 Nicotinic acid chloride hydrochloride 4.0y1 8ml of triethylamine is added to 100ml of chloroform and heated under reflux for 2 hours.
反応液を減圧下に濃縮し、残留物に氷水を加えて放置す
ると晶出してくる。これを■取、水洗後、ベンゼン−イ
ソプロピルエーテル混合溶媒から再結晶すると無色針状
晶である融点126℃の4−〔2−(4−ニコチノイル
アミノメチルフエニル)エチル〕−1−(2−メトキシ
フェニル)ピペラジン4.2yが得られる。実施例34
−〔2−(4−アミノメチルフェニル)エチル〕−1−
(2−メトキシフェニル)ピペラジン4.0q..P−
フルオロベンズアルデヒド1.7yをアルコール50m
L中に加え、水浴上3扮加熱する。The reaction solution is concentrated under reduced pressure, ice water is added to the residue, and when it is left to stand, crystals begin to form. This was collected (2), washed with water, and then recrystallized from a mixed solvent of benzene-isopropyl ether to form colorless needle-shaped crystals of 4-[2-(4-nicotinoylaminomethylphenyl)ethyl]-1-(2) with a melting point of 126°C. -methoxyphenyl)piperazine 4.2y is obtained. Example 34
-[2-(4-aminomethylphenyl)ethyl]-1-
(2-methoxyphenyl)piperazine 4.0q. .. P-
1.7y of fluorobenzaldehyde and 50m of alcohol
Add to L and heat on a water bath for 3 minutes.
次いで、氷冷し、水素化ホウ素ナトリウムを用いて還元
する。減圧下に濃縮し、残留物に水を加え、クロロホル
ム100mtを用いて抽出、水洗後硫酸マグネシウムで
乾燥、減圧下に溶媒を留去し、残留物に2.5%HCl
−イソプロパノールを加えて塩酸塩とする。生じた結晶
をエタノールから再結晶すると無色鱗片状晶である融点
277C(分解)の4−(2−〔4−(4−フルオロベ
ンジルアミノメチル)フェニル〕エチル)−1−(2−
メトキシフェニル)ピペラジン●2塩酸塩3.8yが得
られる。実施例4
4−(4−アセチルアミノメチルフエナシル)−1−フ
エニルピペラジン20y1ヒドラジンヒドラート5m1
をn−ブタノール200mL中に加え、5時間加熱還流
する。It is then cooled on ice and reduced using sodium borohydride. Concentrate under reduced pressure, add water to the residue, extract with 100 mt of chloroform, wash with water, dry over magnesium sulfate, remove the solvent under reduced pressure, and add 2.5% HCl to the residue.
- Add isopropanol to make hydrochloride. When the resulting crystals are recrystallized from ethanol, 4-(2-[4-(4-fluorobenzylaminomethyl)phenyl]ethyl)-1-(2-
3.8y of methoxyphenyl)piperazine●dihydrochloride are obtained. Example 4 4-(4-acetylaminomethylphenacyl)-1-phenylpiperazine 20y1 hydrazine hydrate 5ml
was added to 200 mL of n-butanol and heated under reflux for 5 hours.
冷後氷水中に注ぎ込み、析出する結晶を沖取、水洗後乾
燥するとヒドラゾン16yが得られる。このヒドラゾン
10fとカリウム第“三級ブトキサイド5f1をトルエ
ン200mL中に加え、一夜攪拌還流する。水洗後、減
圧下に濃縮して得られた油状物を冷却し、生じた結晶を
酢酸エチルから再結晶すると無色鱗片状晶である融点1
45℃の4−〔2−(4−アセチルアミノメチルフェニ
ル)エチル〕−1−フエニルピペラジン2.5yが得ら
れる。同様にして以下の化合物が合成できる。After cooling, the mixture is poured into ice water, and the precipitated crystals are collected, washed with water, and dried to obtain hydrazone 16y. This hydrazone 10f and potassium tert-butoxide 5f1 are added to 200 mL of toluene, and stirred and refluxed overnight. After washing with water, the oil obtained by concentrating under reduced pressure is cooled, and the resulting crystals are recrystallized from ethyl acetate. Then, the melting point of colorless scaly crystals is 1.
2.5y of 4-[2-(4-acetylaminomethylphenyl)ethyl]-1-phenylpiperazine at 45° C. is obtained. The following compounds can be synthesized in a similar manner.
Claims (1)
ルキル基、ヒドロキシ低級アルキル基、アリール基、ピ
リジル基、アルアルキル基、テニル基またはピリジル低
級アルキル基を、R^2は水素原子、ハロゲン原子、ア
ミノ基、ニトロ基または水酸基を、Yはアミノ基、低級
アルキルアミノ基、アルアルキルアミノ基、水酸基、一
般式R^3CONH−(式中、R^3は水素原子、低級
アルキル基、アリール基またはピリジル基で示される基
または一般式R^3COO−(式中、R^3は前記と同
義)で示される基を示す。 〕で示されるピペラジン誘導体及びその酸付加塩。[Claims] 1 General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [In the formula, A and B are lower alkylene groups, R^1 is lower alkyl group, hydroxy lower alkyl group, aryl group, pyridyl group , aralkyl group, thenyl group or pyridyl lower alkyl group, R^2 is a hydrogen atom, halogen atom, amino group, nitro group or hydroxyl group, Y is an amino group, lower alkylamino group, aralkylamino group, hydroxyl group, With the general formula R^3CONH- (wherein R^3 is a hydrogen atom, a lower alkyl group, an aryl group, or a group represented by a pyridyl group) or with the general formula R^3COO- (wherein R^3 has the same meaning as above) Piperazine derivatives and acid addition salts thereof represented by the following.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP51074057A JPS6045190B2 (en) | 1976-06-22 | 1976-06-22 | Piprazine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP51074057A JPS6045190B2 (en) | 1976-06-22 | 1976-06-22 | Piprazine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS52156879A JPS52156879A (en) | 1977-12-27 |
JPS6045190B2 true JPS6045190B2 (en) | 1985-10-08 |
Family
ID=13536169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51074057A Expired JPS6045190B2 (en) | 1976-06-22 | 1976-06-22 | Piprazine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6045190B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100342947B1 (en) * | 1997-04-30 | 2002-08-22 | 주식회사 엘지씨아이 | Arylpiperazine derivatives having herbicidal activity |
ES2237850T3 (en) * | 1997-10-14 | 2005-08-01 | Mitsubishi Pharma Corporation | PIPERAZINE COMPOUNDS AND THEIR MEDICINAL USE. |
-
1976
- 1976-06-22 JP JP51074057A patent/JPS6045190B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS52156879A (en) | 1977-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR0159099B1 (en) | 2-amino pyrimidinone derivatives | |
JP2667987B2 (en) | Method for producing 5- [2- (4- (benzoisothiazol-3-yl) -piperazin-1-yl) ethyl] -6-chloro-1,3-dihydro-indol-2-one and intermediate for production | |
JPS58103362A (en) | Manufacture of 4-hydroxyindole derivative and 4-oxo-4,5,6,7-tetrahydroindole derivative | |
EP2542544A1 (en) | Ketobenzofuran derivatives, method for synthesising same, and intermediates | |
EP0217700B1 (en) | Benzimidazole derivatives, their preparation and their therapeutical use | |
JPH06502384A (en) | Anti-inflammatory 4-aminophenol derivative | |
AU658729B2 (en) | 3-(1H-imidazol-1-ylmethyl)-1H-indole derivatives | |
US6037475A (en) | Synthesis of indolymaleimides | |
JPS6019305B2 (en) | Dihydrobenzofuran derivative | |
US5859261A (en) | Synthesis of indolylmaleimides | |
JPS6045190B2 (en) | Piprazine derivative | |
EP1534705B1 (en) | Process for preparing zolmitriptan compounds | |
EP0511031A1 (en) | 3-Aryl-oxazolidinon derivatives, process for their preparation and their use in therapeutics | |
JP2001261653A5 (en) | ||
JPH01156966A (en) | Pyridazinone, triazinone and oxapyridazinone compounds having lipoxygenase inhibiting action | |
JPS5813540B2 (en) | 1,2,3,4- Tetrahydroisoquinoline luino | |
JPS6126992B2 (en) | ||
JPH0159273B2 (en) | ||
NO115019B (en) | ||
JP2006505578A (en) | 5- (2- (4- (1,2benzisothiazol-3-yl) -1-piperazinyl) ethyl) -6-chloro-1,3-dihydro-2H-indol-2-one having neuroleptic activity Acyl derivatives of | |
JPS5811878B2 (en) | Furo (3 2-B) India-Ruruino Seihou | |
SU999967A3 (en) | Process for producing 6-n-substituted 6-amino-3-pyridazinyl hydrizines or their salts | |
JPS5939417B2 (en) | Method for producing amino alcohol derivatives | |
JPS6147837B2 (en) | ||
JPS6087284A (en) | Succinimide derivative and its acid addition salt |